# FAQ

URL: https://nurevo.health/faq
Last updated: 2026-11-01

> Nurevo is the brand of Nurevo Technology Limited, company number SC892389.

## Investors

### What stage is it at?

Nurevo is at pre-seed stage. There is a working prototype of the data pipeline, and Nurevo is preparing clinical validation.

## NHS and clinicians

### Is Nurevo a diagnostic tool?

No. Nurevo is a screening and triage tool. It is not a diagnostic device.

### How does it work?

A short guided conversation on a phone or laptop is analysed across speech, language and facial signals, together with background information, to produce an explainable risk score.

### Which populations is it designed for?

Nurevo is designed for diverse, multilingual populations. Screening is not built around one language or culture.

### Is it available for clinical use?

Not yet. Nurevo is in development and is not currently available for clinical use.

### Has Nurevo been tested in clinical studies?

Not yet. Nurevo is at prototype stage and is preparing clinical validation. No performance figures are published.

### Is Nurevo a medical device?

Not at present. Nurevo holds no conformity marking and no regulatory clearance. Nurevo intends to follow the UK pathway for software as a medical device, overseen by the MHRA.

### Can my organisation take part in a pilot?

We welcome conversations about future pilots and research. Nurevo is not yet available for clinical use. Use the clinical and research partners route on the contact page.

### Who is it for?

Nurevo is for health systems and memory services, for primary care, for care homes and community organisations, and for pharmaceutical companies and contract research organisations.

## Research partners

### How is data protected?

Nurevo designs for consent, UK GDPR and data minimisation. Please do not include personal health information in messages sent through this website.

### Where is data stored?

The storage region has not been published. The service is being designed around consent, UK GDPR and data minimisation.

## Pharma and CROs

### Can Nurevo support clinical trial recruitment?

Nurevo is being designed to support recruitment and stratification for early-stage trials. It is in development and not yet available for use in trials. Use the clinical and research partners route on the contact page.

## Care providers

### Does it need special equipment?

No. The conversation is designed for everyday devices: a phone or a laptop.

## General

### What does Nurevo do?

Nurevo builds AI cognitive screening that turns a short, natural conversation into an explainable risk score for cognitive decline, helping clinicians decide who needs specialist assessment first. In plain terms, Nurevo is building this screening for dementia.

### How is it different?

Nurevo is multimodal rather than single-signal, built for multilingual populations from the start, and explainable by design. It is low-burden and conversational.

### Where is Nurevo based?

Nurevo is headquartered in Edinburgh, United Kingdom. The team is based in the UK, with team members internationally. Nurevo Technology Limited is registered in Scotland, company number SC892389. The registered office is 89/63 Holyrood Road, Edinburgh, EH8 8BA, United Kingdom.

### How can I contact Nurevo?

Use the contact page, or email info@nurevo.tech. Investment, clinical, research and media messages all go to that address.

## The public

### Can I use Nurevo to check my memory?

Not at the moment. Nurevo is in development and is not available for clinical or personal use. If you are worried about your memory, speak to your GP.

---

Nurevo Technology Limited is registered in Scotland, company number SC892389. Registered office: 89/63 Holyrood Road, Edinburgh, EH8 8BA.

Nurevo is a screening and triage tool in development. It is not a diagnostic device and is not currently available for clinical use.